Scaling Up: Fueling Growth by Investing Strategically | Investing in Life Science 2024

Panel discussion themed “Scaling Up: Fueling Growth by Investing Strategically” that debated strategies of expert investment decisions within the life science space. What key factors are considered when predicting growth potential? What constitutes a validated investment case? What aspects are crucial for a company to attract investment?
Dawid Myslinski, a Partner at Vator Securities specializing in equity capital markets, moderated the panel. He was joined on stage by Karl Tobieson, CEO of Linc, a product-oriented life science investment firm; Karl-Fredrik Johannesson, founder of NV and a visionary investor; and Shamim Dadvar, a Medical Associate at HealthCap and MD turned life science venture capitalist.
On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to Success. The event covered the various capital needs in a life science company’s life cycle and highlighted the demands and expectations of investors who provide the funds.
From early-stage investments, where business angels and seed investors drive medical breakthroughs, to growth-stage investments empowering promising ventures to become ready for partnering and/or fueling market expansion and later-stage strategic investments accelerating growth and facilitating a global market presence.
The “Investing in life science: From seed to success” event catered to life science companies in all development stages, who gained insight from investors in the various life cycle stages, simultaneously providing investors a chance to pick the brains of peers, engage in thought-provoking discussions and meet life science companies in early-to-commercial stages.
Subscribe and follow BioStock on:
UA-cam bit.ly/Biostock
LinkedIn: / biostock
Facebook: / biostock.se
www.biostock.se/
#BioStock #LifeScience
About BioStock
BioStock is Scandinavia's leading digital news and analysis service, exclusively focusing on the Life Science sector. Our primary editorial office and tv-studio are found at Medicon Village in Lund, one of Sweden's foremost innovation clusters for life science companies